Cargando…

Assembly Mechanism of Mucin and von Willebrand Factor Polymers

The respiratory and intestinal tracts are exposed to physical and biological hazards accompanying the intake of air and food. Likewise, the vasculature is threatened by inflammation and trauma. Mucin glycoproteins and the related von Willebrand factor guard the vulnerable cell layers in these divers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javitt, Gabriel, Khmelnitsky, Lev, Albert, Lis, Bigman, Lavi Shlomo, Elad, Nadav, Morgenstern, David, Ilani, Tal, Levy, Yaakov, Diskin, Ron, Fass, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599080/ https://www.ncbi.nlm.nih.gov/pubmed/33031746 http://dx.doi.org/10.1016/j.cell.2020.09.021

Ejemplares similares

Assembly of von Willebrand factor tubules with in vivo helical parameters requires A1 domain insertion
por: Javitt, Gabriel, et al.
Publicado: (2022)

Intestinal Gel-Forming Mucins Polymerize by Disulfide-Mediated Dimerization of D3 Domains
por: Javitt, Gabriel, et al.
Publicado: (2019)

Helical self-assembly of a mucin segment suggests an evolutionary origin for von Willebrand factor tubules
por: Javitt, Gabriel, et al.
Publicado: (2022)

Conformational Analysis of Charged Homo-Polypeptides
por: Bigman, Lavi S., et al.
Publicado: (2023)

ssDNA diffuses along replication protein A via a reptation mechanism
por: Mishra, Garima, et al.
Publicado: (2020)

What Are the Molecular Requirements for Protein Sliding along DNA?
por: Bigman, Lavi S., et al.
Publicado: (2021)

Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces
por: Warszawski, Shira, et al.
Publicado: (2019)

Correction: Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces
por: Warszawski, Shira, et al.
Publicado: (2020)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

cis‐Proline mutants of quiescin sulfhydryl oxidase 1 with altered redox properties undermine extracellular matrix integrity and cell adhesion in fibroblast cultures
por: Javitt, Gabriel, et al.
Publicado: (2018)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Von Willebrand Disease: An Overview
por: Bharati, K. Pavani, et al.
Publicado: (2011)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
por: Favaloro, Emmanuel J.
Publicado: (2020)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Negatively charged, intrinsically disordered regions can accelerate target search by DNA-binding proteins
por: Wang, Xi, et al.
Publicado: (2023)

The intestinal MUC2 mucin C-terminus is stabilized by an extra disulfide bond in comparison to von Willebrand factor and other gel-forming mucins
por: Gallego, Pablo, et al.
Publicado: (2023)

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
por: Kalot, Mohamad A., et al.
Publicado: (2021)

Treatment of patients with von Willebrand disease
por: Tuohy, Emma, et al.
Publicado: (2011)

The Molecular Genetics of von Willebrand Disease
por: Berber, Ergül
Publicado: (2012)

Von Willebrand Factor, Angiodysplasia and Angiogenesis
por: Randi, Anna M., et al.
Publicado: (2013)

Regulation of plasma von Willebrand factor
por: Desch, Karl C
Publicado: (2018)

Von Willebrand's Disease: Pathogenesis and Management
por: Dormandy, Katharine M.
Publicado: (1969)

Report on von Willebrand Disease in Malaysia
por: Periayah, Mercy Halleluyah, et al.
Publicado: (2016)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
por: Boender, Johan, et al.
Publicado: (2021)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
por: Casonato, Alessandra, et al.
Publicado: (2021)

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
por: Leebeek, Frank W. G., et al.
Publicado: (2022)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)

A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
por: Lai, Shiue-Wei, et al.
Publicado: (2021)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
por: Bauer, Alexander, et al.
Publicado: (2023)

Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review
por: Sun, Shawn X., et al.
Publicado: (2023)

Evaluation of von Willebrand factor in COPD patients
por: Bártholo, Thiago Prudente, et al.
Publicado: (2014)

Treatment of patients with von Willebrand disease [Erratum]
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ega2sosp200u3q9in35b468uhj